F Hoffmann - Roche Holding Insider

Roche Holding AG -- USA Stock  

USD 229.10  0.000006  0.00%

IR Contact Officer

We currently do not have informatin regarding F Hoffmann. This executive tanure with Roche Holding AG is not currenlty determined.
  Executive Since 2014      
41 61 688 11 11  http://www.roche.com

Management Efficiency

The company has return on total asset (ROA) of 14.37 % which means that it generated profit of $14.37 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 31.85 % meaning that it generated $31.85 on every $100 dollars invested by stockholders.
The company has accumulated 19.8 B in total debt with debt to equity ratio (D/E) of 65.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Roche Holding AG has Current Ratio of 1.39 which is within standard range for the sector.

Similar Executives

Entity Summary

Roche Holding AG diagnostics and pharmaceuticals businesses in Switzerland, Germany, and rest of Europe. The company was founded in 1896 and is headquartered in Basel, Switzerland. Roche Holding operates under Drug Manufacturers - Major classification in USA and traded on OTC Market. It employs 93734 people.Roche Holding AG (RHHBF) is traded on OTC Market in USA. It is located in Konzern Hauptsitz and employs 93,734 people.

Roche Holding AG Leadership Team

Osamu Nagayama, CEO
Michael Varney, Executive, Ph.D
Silvia Ayyoubi, Executive
Sophie KornowskiBonnet, Executive
Beatrice Mauro, Director
Cristina Wilbur, Executive
Roland Diggelmann, COO
Gottlieb Keller, Executive, Ph.D
Urs Jaisli, Executive
Daniel ODay, COO, MBA
DeAnne Julius, Director
Karl Mahler, Executive
Andre Hoffmann, Chairman, MBA
John Reed, Executive, Ph.D
Claudia Dyckerhoff, Director, Ph.D
Fritz Gerber, Chairman, Ph.D
Stephan Feldhaus, Executive, Ph.D
Julie Brown, Director
Richard Lifton, Director
Paul Bulcke, Director
Christoph Franz, Director
PerOlof Attinger, CEO
Pius Baschera, Director, Ph.D
Peter Voser, Director
Bernard Poussot, Director
John Bell, Director, Ph.D
Andreas Oeri, Director, Ph.D
Alan Hippe, CFO
F Hoffmann, Executive
Severin Schwan, CEO, Ph.D
Anita Hauser, Director

Stock Performance Indicators

Did you try this?

Run Portfolio Rebalancing Now
   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Hide  View All  NextLaunch Portfolio Rebalancing

Trending Equities

Currently Active Assets on Macroaxis
VMW   
 NYQ 
Purchased over 20 shares of
few hours ago ago
Traded for 137.54
F   
 NYQ 
Purchased over 200 shares of
few hours ago ago
Traded for 11.33
V   
 NYQ 
Purchased over 20 shares of
few hours ago ago
Traded for 124.48
GM   
 NYQ 
Purchased over 70 shares of
few hours ago ago
Traded for 38.93
F   
 NYQ 
Purchased over 200 shares of
few hours ago ago
Traded for 11.33
RKDA   
 NCM 
Purchased over 100 shares of
few hours ago ago
Traded for 25.72
Additionally take a look at Your Equity Center. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.